Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Global Report 2026

The ribonucleic acid (RNA) isolation and enrichment reagent market size has grown rapidly in recent years. It will grow from $0.94 billion in 2025 to $1.04 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to rising demand for molecular diagnostics in infectious diseases, increasing adoption of next generation sequencing technologies, growth in academic and clinical genomics research funding, expansion of biobanking and sample preservation infrastructure, early adoption of manual rna extraction methods in laboratories.

The ribonucleic acid (RNA) isolation and enrichment reagent market size is expected to see rapid growth in the next few years. It will grow to $1.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing shift toward automated and high throughput rna isolation systems, rising demand for precision medicine and transcriptomics based drug discovery, growing use of AI driven bioinformatics for rna data interpretation, expansion of personalized medicine and rare disease research programs, increasing integration of lab robotics and digital lab ecosystems. Major trends in the forecast period include increasing adoption of automated rna extraction platforms integrated with laboratory robotics, growing demand for high purity rna isolation kits for next generation sequencing workflows, expansion of low input and single cell rna isolation solutions for advanced genomics research, rising use of magnetic bead based purification technologies for improved yield and scalability, increasing integration of cloud connected laboratory informatics systems for rna workflow optimization.

The increasing genomics research activities are expected to propel the growth of the ribonucleic acid (RNA) isolation and enrichment reagent market going forward. Genomics research activities involve expanding scientific investigations focused on gene sequencing, transcriptomics, RNA analysis, and molecular biology. These activities are increasing due to the growing demand for precision medicine, which depends on comprehensive genetic analysis to develop targeted therapies and personalized treatment approaches. Ribonucleic acid (RNA) isolation and enrichment reagents support genomics research by enabling the extraction and purification of high-quality RNA for sequencing, transcriptomics, and gene expression analysis, improving data accuracy and the reliability of downstream molecular research. For instance, in July 2023, according to a report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of the first quarter (Q1) 2023, there were 247 gene therapies in Phase II, but this number rose by 5% to reach 260 by the end of the second quarter (Q2), reflecting growing genomics and genetic research activities. Therefore, the increasing genomics research activities are driving the growth of the ribonucleic acid (RNA) isolation and enrichment reagent market.

Major companies operating in the ribonucleic acid (RNA) isolation and enrichment reagents market are emphasizing the development of one-step viral RNA extraction kits to enhance diagnostic speed, improve accuracy, and streamline workflows in infectious disease testing. One-step viral RNA extraction kits are specialized molecular diagnostic solutions designed to rapidly isolate high-quality nucleic acids from clinical samples while reducing processing steps, lowering contamination risks, and eliminating the need for complex equipment. For instance, in September 2025, Xpedite Diagnostics GmbH, a Germany-based biotechnology company, launched SwiftX Virus, a CE-IVD-certified one-step viral RNA extraction kit for human serum and plasma. It is intended for professional diagnostic and point-of-care applications. The kit provides PCR-ready viral RNA and bacterial DNA in just six minutes using proprietary reverse purification technology, removing the need for centrifuges, spin columns, or hazardous solvents. The solution demonstrated 98% sensitivity and 100% specificity across several tropical and vector-borne pathogens, including Dengue, Chikungunya, Yellow Fever, West Nile Virus, and Leptospira, enabling faster and more reliable molecular diagnostics in both clinical and outbreak-response settings.

In January 2023, ALS Limited, an Australia-based testing laboratory company, acquired Invitek Molecular GmbH for an undisclosed amount. Through this acquisition, ALS Limited aimed to reinforce its molecular diagnostics and life sciences capabilities, expand its range of sample preparation and nucleic acid extraction solutions, and increase its footprint in the global biotechnology and clinical testing markets. Invitek Molecular GmbH is a Germany-based provider of nucleic acid isolation kits, molecular diagnostic reagents, sample preparation technologies, and automated purification solutions for research, clinical, and industrial applications.

Major companies operating in the ribonucleic acid (RNA) isolation and enrichment reagent market report are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Cytiva Sweden AB, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, Takara Bio Inc., MP Biomedicals LLC, Analytik Jena GmbH+Co. KG, Macherey-Nagel GmbH & Co. KG, New England Biolabs Inc., Zymo Research Corporation, Bioneer Corporation, Yeasen Biotechnology (Shanghai) Co. Ltd., Tiangen Biotech (Beijing) Co. Ltd., Geneaid Biotech Ltd., HiMedia Laboratories Pvt. Ltd., Norgen Biotek Corp., Vazyme Biotech Co. Ltd., Illumina Inc., 10x Genomics Inc., Covaris LLC.

North America was the dominating region in the ribonucleic acid (RNA) isolation and enrichment reagent market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) isolation and enrichment reagent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) isolation and enrichment reagent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.